158 related articles for article (PubMed ID: 31647372)
21. ERCC5 p.Asp1104His and ERCC2 p.Lys751Gln polymorphisms are independent prognostic factors for the clinical course of melanoma.
Schrama D; Scherer D; Schneider M; Zapatka M; Bröcker EB; Schadendorf D; Ugurel S; Kumar R; Becker JC
J Invest Dermatol; 2011 Jun; 131(6):1280-90. PubMed ID: 21390047
[TBL] [Abstract][Full Text] [Related]
22. Nucleotide Excision Repair Capacity and XPC and XPD Gene Polymorphism Modulate Colorectal Cancer Risk.
Mucha B; Pytel D; Markiewicz L; Cuchra M; Szymczak I; Przybylowska-Sygut K; Dziki A; Majsterek I; Dziki L
Clin Colorectal Cancer; 2018 Jun; 17(2):e435-e441. PubMed ID: 29793654
[TBL] [Abstract][Full Text] [Related]
23. Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer.
Xue MH; Li GY; Wu XJ; Zhang CX; Zhang CF; Zhu KX
Int J Clin Exp Pathol; 2015; 8(5):5563-9. PubMed ID: 26191265
[TBL] [Abstract][Full Text] [Related]
24. Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysis.
Kiyohara C; Yoshimasu K
Int J Med Sci; 2007 Feb; 4(2):59-71. PubMed ID: 17299578
[TBL] [Abstract][Full Text] [Related]
25. Single nucleotide polymorphisms in nucleotide excision repair genes XPA, XPD, XPG and ERCC1 in advanced colorectal cancer patients treated with first-line oxaliplatin/fluoropyrimidine.
Monzo M; Moreno I; Navarro A; Ibeas R; Artells R; Gel B; Martinez F; Moreno J; Hernandez R; Navarro-Vigo M
Oncology; 2007; 72(5-6):364-70. PubMed ID: 18204222
[TBL] [Abstract][Full Text] [Related]
26. The genotype distribution of the XRCC1, XRCC3, and XPD DNA repair genes and their role for the development of acute myeloblastic leukemia.
Sorour A; Ayad MW; Kassem H
Genet Test Mol Biomarkers; 2013 Mar; 17(3):195-201. PubMed ID: 23397959
[TBL] [Abstract][Full Text] [Related]
27. Laryngeal cancer risk and common single nucleotide polymorphisms in nucleotide excision repair pathway genes ERCC1, ERCC2, ERCC3, ERCC4, ERCC5 and XPA.
Lu B; Li J; Gao Q; Yu W; Yang Q; Li X
Gene; 2014 May; 542(1):64-8. PubMed ID: 24582975
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China.
Shen M; Berndt SI; Rothman N; Demarini DM; Mumford JL; He X; Bonner MR; Tian L; Yeager M; Welch R; Chanock S; Zheng T; Caporaso N; Lan Q
Int J Cancer; 2005 Sep; 116(5):768-73. PubMed ID: 15849729
[TBL] [Abstract][Full Text] [Related]
29. XRCC3 Thr241Met and XPD Lys751Gln gene polymorphisms and risk of clear cell renal cell carcinoma.
Loghin A; Bănescu C; Nechifor-Boila A; Chibelean C; Orsolya M; Nechifor-Boila A; Tripon F; Voidazan S; Borda A
Cancer Biomark; 2016; 16(2):211-7. PubMed ID: 26682510
[TBL] [Abstract][Full Text] [Related]
30. Genetic variation in the nucleotide excision repair pathway and bladder cancer risk.
García-Closas M; Malats N; Real FX; Welch R; Kogevinas M; Chatterjee N; Pfeiffer R; Silverman D; Dosemeci M; Tardón A; Serra C; Carrato A; García-Closas R; Castaño-Vinyals G; Chanock S; Yeager M; Rothman N
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):536-42. PubMed ID: 16537713
[TBL] [Abstract][Full Text] [Related]
31. Nucleotide excision repair pathway gene polymorphisms are associated with risk and prognosis of colorectal cancer.
Li YK; Xu Q; Sun LP; Gong YH; Jing JJ; Xing CZ; Yuan Y
World J Gastroenterol; 2020 Jan; 26(3):307-323. PubMed ID: 31988591
[TBL] [Abstract][Full Text] [Related]
32. DNA repair gene associated with clinical outcome of epithelial ovarian cancer treated with platinum-based chemotherapy.
Kang S; Sun HY; Zhou RM; Wang N; Hu P; Li Y
Asian Pac J Cancer Prev; 2013; 14(2):941-6. PubMed ID: 23621265
[TBL] [Abstract][Full Text] [Related]
33. Contribution of DNA Repair Xeroderma Pigmentosum Group D Genotypes to Colorectal Cancer Risk in Taiwan.
Chang WS; Yueh TC; Tsai CW; Ji HX; Wu CN; Wang SC; Lai YL; Hsu SW; Hsieh MH; Hsiao CL; Hung YW; Shih TC; Bau DT
Anticancer Res; 2016 Apr; 36(4):1657-63. PubMed ID: 27069143
[TBL] [Abstract][Full Text] [Related]
34. Roles of XRCC1/XPD/ERCC1 Polymorphisms in Predicting Prognosis of Hepatocellular Carcinoma in Patients Receiving Transcatheter Arterial Chemoembolization.
Wang XC; Wang F; Quan QQ
Genet Test Mol Biomarkers; 2016 Apr; 20(4):176-84. PubMed ID: 26918371
[TBL] [Abstract][Full Text] [Related]
35. XPD Lys751Gln polymorphism in the etiology and outcome of childhood acute myeloid leukemia: a Children's Oncology Group report.
Mehta PA; Alonzo TA; Gerbing RB; Elliott JS; Wilke TA; Kennedy RJ; Ross JA; Perentesis JP; Lange BJ; Davies SM;
Blood; 2006 Jan; 107(1):39-45. PubMed ID: 16150943
[TBL] [Abstract][Full Text] [Related]
36. DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population.
Chen S; Tang D; Xue K; Xu L; Ma G; Hsu Y; Cho SS
Carcinogenesis; 2002 Aug; 23(8):1321-5. PubMed ID: 12151350
[TBL] [Abstract][Full Text] [Related]
37. Polymorphisms in the DNA repair genes XPD (ERCC2) and XPF (ERCC4) are not associated with sporadic late-onset Alzheimer's disease.
Dogru-Abbasoglu S; Inceoglu M; Parildar-Karpuzoglu H; Hanagasi HA; Karadag B; Gurvit H; Emre M; Aykac-Toker G; Uysal M
Neurosci Lett; 2006 Sep; 404(3):258-61. PubMed ID: 16806697
[TBL] [Abstract][Full Text] [Related]
38. Polymorphisms of DNA repair genes XPD and XRCC1 and risk of cataract development.
Unal M; Güven M; Batar B; Ozaydin A; Sarici A; Devranoğlu K
Exp Eye Res; 2007 Sep; 85(3):328-34. PubMed ID: 17637462
[TBL] [Abstract][Full Text] [Related]
39. Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy.
Ryu JS; Hong YC; Han HS; Lee JE; Kim S; Park YM; Kim YC; Hwang TS
Lung Cancer; 2004 Jun; 44(3):311-6. PubMed ID: 15140544
[TBL] [Abstract][Full Text] [Related]
40. Associated risk of XRCC1 and XPD cross talk and life style factors in progression of head and neck cancer in north Indian population.
Kumar A; Pant MC; Singh HS; Khandelwal S
Mutat Res; 2012 Jan; 729(1-2):24-34. PubMed ID: 21945240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
